Search research articles
Contact Us
Filters
Showing results (141-150 of 163) with videos related to
Page
of 17
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 30, 2022
Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines
Alexandre Louvet, Jean-Baptiste Trabut, Christophe Moreno, et al.
Journal of Hepatology
|
July 13, 2025
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial
Thierry Thévenot, Laure Elkrief, Christophe Bureau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Gastroenterology
|
August 26, 2018
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
Richard Moreau, Laure Elkrief, Christophe Bureau, et al.
Hepatology (Baltimore, Md.)
|
July 13, 2020
Intestinal Virome in Patients With Alcoholic Hepatitis
Lu Jiang, Sonja Lang, Yi Duan, et al.
Gastroenterology
|
December 14, 2020
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
Veronica Massey, Austin Parrish, Josepmaria Argemi, et al.
Gastroenterology
|
January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitis
José Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Alcohol (Fayetteville, N.Y.)
|
December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Cell Host & Microbe
|
May 29, 2025
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease
Yongqiang Yang, Yi Duan, Sonja Lang, et al.
Nature Reviews. Gastroenterology & Hepatology
|
September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 163) with videos related to
Sort By:
Page
of 17
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 30, 2022
Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines
Alexandre Louvet, Jean-Baptiste Trabut, Christophe Moreno, et al.
Journal of Hepatology
|
July 13, 2025
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial
Thierry Thévenot, Laure Elkrief, Christophe Bureau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Gastroenterology
|
August 26, 2018
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
Richard Moreau, Laure Elkrief, Christophe Bureau, et al.
Hepatology (Baltimore, Md.)
|
July 13, 2020
Intestinal Virome in Patients With Alcoholic Hepatitis
Lu Jiang, Sonja Lang, Yi Duan, et al.
Gastroenterology
|
December 14, 2020
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
Veronica Massey, Austin Parrish, Josepmaria Argemi, et al.
Gastroenterology
|
January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitis
José Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Alcohol (Fayetteville, N.Y.)
|
December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Cell Host & Microbe
|
May 29, 2025
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease
Yongqiang Yang, Yi Duan, Sonja Lang, et al.
Nature Reviews. Gastroenterology & Hepatology
|
September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Page
of 17